Pharmaceutical Sterility Testing Market, Global Outlook and Forecast 2023-2029

Sterility testing is an important part of GMP microbiology, and is used to ensure that pharmaceutical and biopharmaceutical therapeutics are sterile and safe for human use.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Sterility Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Sterility Testing. This report contains market size and forecasts of Pharmaceutical Sterility Testing in global, including the following market information:
Global Pharmaceutical Sterility Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pharmaceutical Sterility Testing market was valued at US$ 857.3 million in 2022 and is projected to reach US$ 1324.5 million by 2029, at a CAGR of 6.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Government investments in the healthcare industry, increasing RandD activities and number of drug launches, and rising focus on quality and sterility are projected to drive the market. According to UNESCO report, U.S., China, Japan, and Germany were among the top five nations in terms of RandD expenditure in 2016.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Sterility Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Sterility Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceutical Sterility Testing Market Segment Percentages, by Type, 2022 (%)
    Sterility Testing
    Bioburden Testing
    Bacterial Endotoxin Testing
Global Pharmaceutical Sterility Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceutical Sterility Testing Market Segment Percentages, by Application, 2022 (%)
    Compounding Pharmacies
    Medical Devices Companies
    Pharmaceutical Companies
    Others
Global Pharmaceutical Sterility Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pharmaceutical Sterility Testing Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Sterility Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharmaceutical Sterility Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    SGS SA
    Toxikon, Inc.
    Pace Analytical Services, LLC
    Boston Analytical
    Charles River Laboratories International, Inc.
    Nelson Laboratories.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical Sterility Testing, market overview.
Chapter 2: Global Pharmaceutical Sterility Testing market size in revenue.
Chapter 3: Detailed analysis of Pharmaceutical Sterility Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Sterility Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.